M. Bauer

Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy

M. Lichtblau, K. Bloch, M. Furian, 2023, European heart journal.

Heart rate variability in pulmonary vascular disease at altitude: a randomised trial

M. Lichtblau, K. Bloch, M. Furian, 2024, ERJ open research.

The effect of high altitude (2500 m) on incremental cycling exercise in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomised controlled crossover trial

M. Lichtblau, K. Bloch, M. Furian, 2024, European Respiratory Journal.